[
    {
        "id": "osp-2605",
        "type": "article-journal",
        "title": "Management of Malignant Otitis Externa with Hyperbaric Oxygen Therapy: A Case Series of 20 Patients",
        "author": [
            {
                "family": "Al Siyabi",
                "given": "Abdulhameed"
            },
            {
                "family": "Al Farsi",
                "given": "Badriya"
            },
            {
                "family": "Al-Shidhani",
                "given": "Asma"
            },
            {
                "family": "Al Hinai",
                "given": "Zainb"
            },
            {
                "family": "Al Balushi",
                "given": "Yousuf"
            },
            {
                "family": "Al Qartoobi",
                "given": "Hassan"
            }
        ],
        "URL": "https://omanscience.com/en/articles/management-of-malignant-otitis-externa-with-hyperbaric-oxygen-therapy-a-case-series-of-20-patients",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2023
                ]
            ]
        },
        "container-title": "Oman Medical Journal",
        "DOI": "10.5001/omj.2023.19",
        "publisher": "Oman Medical Specialty Board",
        "ISSN": "1999-768X",
        "abstract": "Malignant otitis externa (MOE) is an aggressive infection of the external auditory canal that primarily affects diabetic patients. Some literature supports the effectiveness of hyperbaric oxygen therapy (HBOT) as a treatment modality for MOE. A case series was conducted of all patients diagnosed with MOE and treated with HBOT at the Said Bin Sultan Naval Base Polyclinic in Oman between January 2014 and December 2019. A total of 20 patients were included in the study. All participants presented with persistent ear discharge, 95.0% with otalgia, and 75.0% with granulation in the external auditory canal. Moreover, 100% showed abnormally high levels of inflammatory markers and abnormal computed tomography findings. The patients underwent an average of 29.0±8.9 HBOT sessions. Overall, 19 (95.0%) patients were considered cured by the end of the treatment. The use of HBOT in the management of MOE appears promising and may cure MOE."
    }
]